SZ Inhal

PharmaceuticalsSeries ASuzhou, Chinainhalpharma.com

Latest round

Series A

Last raised

Jun 2025

Total raised

$14M

Investors

3

About SZ Inhal

Founded in 2020 and based in Suzhou, China, SZ Inhal is a pharmaceutical company that focuses on the research and development of inhaled preparations. Jingxu Zhu, the founder of the company, has more than 20 years of experience in inhaled drug delivery research and development. The company has four departments: formulation development, analysis and testing, inhalation device and mechanical equipment development.   The company's main products include dry powder inhalation formulations, reservoir-type, blister-type, capsule-type and disposable inhalation devices. Its products are used in small molecules, peptides, biological macromolecules and other fields. The company’s revenue is generated by providing inhalation preparations, inhalation devices and supporting equipment.

Who invested in SZ Inhal

3 investors across 2 rounds

See all investors in SZ Inhal

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jun 3, 2025

    Amount

    $6.9M

    Investors

    Locked

  2. Series A

    Oct 16, 2023

    Amount

    $6.8M

    Investors

    Locked

Questions about SZ Inhal

Who invested in SZ Inhal?

SZ Inhal has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has SZ Inhal raised?

SZ Inhal has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did SZ Inhal last raise money?

SZ Inhal's most recent round on record is a Series A, in Jun 2025.

What does SZ Inhal do?

Founded in 2020 and based in Suzhou, China, SZ Inhal is a pharmaceutical company that focuses on the research and development of inhaled preparations.

Where is SZ Inhal headquartered?

SZ Inhal is headquartered in Suzhou, China.

Which VCs invest in companies like SZ Inhal?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at SZ Inhal's stage. Their profiles are linked below.

Raising like SZ Inhal? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.